ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Basic/Clinical Science Session

Type 1 Diabetics Are Not Little Type 2s

October 25, 2020 | 10:00 AM - 12:00 PM

Location: On-Demand

Session Description

CKD in type 1 diabetes is similar to that in type 2 diabetes but with key differences and considerations for patient care. New therapies and technologies have been developed to treat diabetes and delay the onset of ESRD and cardiovascular events. This session reviews the current level of evidence for use of these treatments among patients with type 1 diabetes and CKD.

Learning Objective(s)

  • Identify the different patterns of GFR (and proteinuric and non-proteinuric) decline in type 1 diabetes
  • Describe the importance of glycemic control in patients with type 1 diabetes at all stages of diabetic kidney disease
  • Discuss the controversy regarding the use of SGLT (sodium-glucose cotransporter) 2 inhibitors in type 1 diabetes
  • Explain the need for cardio-protective therapies for patients with type 1 diabetes before and after onset of ESRD

Learning Pathway(s)

  • Diabetes and Metabolism


  • Maryam Afkarian, MD, PhD
  • Sylvia E. Rosas, MD, MS, FASN


  • How Does Kidney Disease in Type 1 Differ from Type 2 Diabetes
    10:00 AM - 10:30 AM
    M. Luiza A. Caramori, MD, MS, PhD
  • Challenges to Maintain Glycemic Control in Patients with Type 1 Diabetes and Impaired Renal Function
    10:30 AM - 11:00 AM
    Sarit Polsky, MD, MPH
  • Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Type 1 Diabetes
    11:00 AM - 11:30 AM
    Bruce A. Perkins, MD, MPH 
  • Prevention of Cardiovascular Complications in Patients with Type 1 Diabetes: Before and After ESRD
    11:30 AM - 12:00 PM
    Per-Henrik Groop, MD, PhD